Germany's Pevion Biotech has landed a $30.2 million Series A private financing round. The round was led by the new investor BZ Bank Aktiengesellschaft. BB Biotech Ventures II, CC Private Equity Partners and Bachem Holding also participated. Pevion has three of its vaccines in clinical testing. The company said it will use the funds to push a hepatitis C and breast cancer vaccines into Phase II. It will also fund preclinical vaccine candidates against RSV and Candida infections into clinical development.
- see the release